People who receive one of the Covid-19 vaccines may become the next super propagators because they can believe they are safe from transmitting the virus.
Harvard University public health student Rushabh Doshi made a warning about KevinMD – a platform founded by Dr. Kevin Pho for medical professionals to share their ideas.
Although the various vaccines against Covid-19 and its variants prevent most from developing severe symptoms and dying, the main products may not prevent the virus from continuing to spread.
“Covid-19 vaccines prevent disease, but we know little about whether they prevent reinfection and subsequent viral transmission,” wrote Doshi.
People who receive the Covid-19 vaccine may become the next super propagators because they can believe they are protected against the transmission of the virus. In the photo: Principal Pharmacist, Syed Anas Gilani vaccine Principal Pharmacist, Davinder Manku in Dudley, England on January 25
“In fact, vaccinated populations that act on the assumption that they are immune and therefore cannot spread the virus may become the next super-disseminators.”
Mr Doshi said that vaccinated members of the population who fail to understand that they may still carry the virus “pose an immediate threat to the unvaccinated.”
He said this is important to note due to a ‘slower-than-expected vaccination implementation for the general public’.
The Australian government plans to have as many people vaccinated as possible in 2021 – but implementation will occur in stages.
Frontline residents for the injection include quarantine and frontier workers, frontline health professionals, elderly and disabled people and elderly and disabled people.
Mr. Doshi urged health officials to educate the public about vaccines and that recipients are still aware that they can contract and spread the virus, even if they are safe from serious illness.
“As the population begins to receive the vaccination, scientists fear that measures of social distance and the behavior of wearing masks will diminish,” he wrote.
“We must carefully educate a population facing severe virus fatigue and malaise that, while receiving vaccines appears to prevent serious illnesses, we are not sure whether they significantly reduce the transmission of the virus in the community.”
Harvard University public health student Rushabh Doshi explained that little is known whether vaccinated people can still transmit the coronavirus
The continuing risk of infection has prompted Australian health officials to warn that restrictions – on international travel, at large meetings, wearing masks, etc. – they will probably need to stay in place for months while the vaccine continues to be distributed.
Acting medical director Michael Kidd has lowered expectations that jabs would lead to life by returning to pre-pandemic environments, even after the Pfizer vaccine was approved for use in Australia.
The two main unknowns are whether coronavirus vaccines prevent transmission of the virus and whether booster vaccines will be needed each year, similar to the flu.
“It just reinforces to us how important it will be – even if we can launch the vaccine across Australia – that people still follow public health measures,” Professor Kidd told ABC radio on Tuesday.
Australia has sufficient doses of the Pfizer vaccine, which recorded a 95 percent efficacy rate in end-stage tests, for about five million people.
Elderly and disabled residents will be the first to welcome you with the program scheduled to begin in late February, two weeks after the arrival of the first 80,000 doses.
Quarantined workers, borders, first-line health and residential care for the elderly and disabled are also in the first phase.
However, the limited supply of the Pfizer jab means that most Australians are likely to receive the AstraZeneca jab, which has not yet been approved by the Therapeutic Goods Administration, but which is due for release in March.
The AstraZeneca jab has a lower effectiveness rate of around 70 percent, but it is much easier to transport and store than the Pfizer version, which requires extremely cold conditions – in addition to the capacity of most GP surgeries – and is also much cheaper to produce.
The two vaccines are considerably different in how they operate. The Astra Zeneca product operates like most vaccines – placing a small amount of the weakened virus in the body so that the immune system can create antibodies that destroy it, so if a subsequent real virus infection enters the system, the antibodies will already be present and ready to attack you.
On the other hand, the Pfizer vaccine uses innovative gene-altering technology, ‘teaching’ cells how to produce a specific protein that triggers the immune response if there is a subsequent Covid-19 infection.